Description
Standard and cutting-edge biomarkers used for the diagnosis and evaluation of different illnesses will be covered in this Special Issue. Emphasis will be placed on personalized medicine, since this innovative strategy enables healthcare professionals to identify the most effective therapies for each patient using diagnostic tests and biomarkers. Evidence-based findings indicate that many medications are unsuccessful for some individuals; as such, this method is crucial. Healthcare professionals can create individual preventative plans and treatment plans by considering the patient’s medical history, as well as biomarkers throughout the diagnosis process. This strategy benefits patients and the healthcare system, according to several cost-effectiveness studies. Treatments that are customized for each patient offer both medical and financial benefits, making them not only essential for patients and physicians, but also welcomed by regulatory agencies as well as insurance providers.
